LISA RONNING: Open Payments
NPI 1528711850 · CAMBRIDGE, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$332 in 15 payments from 10 companies in 2025. Trend: 2023 $174 · 2024 $455 · 2025 $332
Food & beverage: $332
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $88 |
| Xeris Pharmaceuticals, Inc. | 2 | $41 |
| Lilly USA, LLC | 2 | $41 |
| Abbott Laboratories | 1 | $29 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $26 |
| Ascendis Pharma Endocrinology Inc | 1 | $26 |
| Alvogen Inc | 1 | $25 |
| Novo Nordisk Inc | 1 | $22 |
| Neurocrine BioSciences, Inc. | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: EVENITY, RECORLEV, FREESTYLE LIBRE 3, TEPEZZA, Kerendia, Yorvipath, TERIPARATIDE, JARDIANCE.
Industry payments across MA — which companies pay providers there.
